Piramal Pharma Solutions
About Piramal Pharma Solutions
Certifications
Categories
-
US
-
2017On CPHI since
-
1Certificates
-
5000+Employees
Company types
Primary activities
Meet us at
CPHI North America 2024
Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Piramal Pharma Solutions Resources (19)
-
News Piramal spends £55m to bolster its UK manufacturing presence
The investment covers two expansions to accommodate several pipeline products moving to commercial scale -
Brochure ADCelerate Rapid Integrated ADC to IND
ADCelerate is Piramal Pharma Solutions’ rapid approach to delivering Phase-Iappropriate ADC drug substance and drug product, so that you can acceleratethe delivery of your product to patients in the clinic. From project initiation toGMP drug product in as little as 12 months, with no compromising on quality -
News Piramal to create screening facility to boost in-vitro biology capabilities
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities -
Video Patient Centricity @ Piramal Pharma Solutions
Patient Centricity @ Piramal Pharma Solutions -
News Piramal adds antibody CDMO capabilities with investment in Yapan Bio
Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering -
Video Recent Updates and Future Plans for Piramal Pharma Solutions
Recent Updates and Future Plans for Piramal Pharma Solutions -
News Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs
The acquisition will add peptide API development and manufacturing capabilities- Peptide drugs are growing significantly in oncology and metabolic therapies- Piramal’s integrated drug substance and drug product offering will now include peptides -
Video Transition to Differentiated Offerings and Value to Consumer
Transition to Differentiated Offerings and Value to Consumer -
News Piramal Pharma Solutions Invests ~$32 Million to Expand its Riverview Michigan Facility for Additional Capacity in Potent and Non-Potent API Development and Manufacturing
The expansion adds both additional capacity and new capabilities in labs and manufacturing- Growing customer demand in the API space is driving the investment- The investment is further validation of the company’s commitment to patients around the world -
Video Piramal Pharma Solutions- V Block, Pithampur, India
Piramal Pharma Solutions- V Block, Pithampur, India -
News Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc
The work will be performed at Piramal Pharma Solutions’ development and manufacturing site in Lexington, KentuckyMSA covers work on Plus Therapeutics’ RNL-Liposome Intermediate Drug Product -
Brochure Generic Peptide APIs
As part of our market-leading expertise in drug substances, Piramal Pharma Solutions offers multigram to kilogram GMP peptides for clinical trials and a deep portfolio of generic peptide APIs. Our GMP manufacturing capabilities include 4,500 liters of reactor volume, while our non-GMP R&D facility features more than twenty scientists with vast experience in peptide chemistry. It’s another example of how we are continually expanding the ways in which we help reduce the burden of disease on patients -
News Piramal Pharma Solutions Announces Sterile Fill Finish Program with Theratechnologies Inc. for TH1902 Peptide-Drug Conjugate
Piramal Pharma Solutions (PPS) is providing drug product formulation and manufacturing from the company’s Lexington, KY site in the U.S. Drug product material will be used in a first-in-humans clinical study -
Brochure Our Capabilities
API sites and Formulation Sites -
News Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle
Piramal Enterprise Limited completes the integration of its pharma businesses into its subsidiary - Piramal Pharma Limited Carlyle completes investment in Piramal Pharma; capital infusion to accelerate Piramal Pharma’s organic and inorganic growth plans
Carlyle’s global healthcare expertise to bring significant value to Piramal Pharma -
Technical Data Case Study
ENERGY REDUCTION IN API DEVELOPMENT & MANUFACTURING -
News Piramal expands its high potency API capability
Becomes one of only a few companies in the contract development and manufacturing market that can produce HPAPIs at such low OELs. -
Technical Data Case Study SOLVENT EFFICIENCY IMPROVEMENT INITIATIVE
SOLVENT EFFICIENCYIMPROVEMENT INITIATIVE -
Brochure Piramal Pharma Solutions Corporate Brochure
Delivering Integrated Solutions Across The Drug Life Cycle
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance